Total Payments
$186,491
2024 Payments
$95.53
Companies
12
Transactions
263
Medicare Patients
4,650
Medicare Billing
$542,781
Payment Breakdown by Category
Other$161,951 (86.8%)
Travel$9,287 (5.0%)
Consulting$8,364 (4.5%)
Food & Beverage$6,760 (3.6%)
Education$129.21 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $161,951 | 108 | 86.8% |
| Travel and Lodging | $9,287 | 33 | 5.0% |
| Consulting Fee | $8,364 | 7 | 4.5% |
| Food and Beverage | $6,760 | 111 | 3.6% |
| Education | $129.21 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $58,759 | 83 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $53,350 | 65 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $29,666 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $21,162 | 41 | $0 (2018) |
| Lilly USA, LLC | $16,284 | 17 | $0 (2021) |
| AbbVie, Inc. | $5,344 | 10 | $0 (2018) |
| Novo Nordisk Inc | $1,668 | 5 | $0 (2021) |
| Abbott Laboratories | $117.38 | 2 | $0 (2021) |
| Dexcom, Inc. | $95.54 | 3 | $0 (2024) |
| Senseonics, Incorporated | $20.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95.53 | 3 | Dexcom, Inc. ($44.50) |
| 2023 | $39.90 | 1 | Dexcom, Inc. ($39.90) |
| 2022 | $12.33 | 1 | Xeris Pharmaceuticals, Inc. ($12.33) |
| 2021 | $5,910 | 12 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,250) |
| 2020 | $12,572 | 23 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,875) |
| 2019 | $21,548 | 28 | Boehringer Ingelheim Pharmaceuticals, Inc. ($12,284) |
| 2018 | $50,708 | 76 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18,470) |
| 2017 | $95,605 | 119 | AstraZeneca Pharmaceuticals LP ($37,344) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $44.50 | General |
| Category: Endocrinology | ||||||
| 04/24/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), TRADJENTA, JARDIANCE | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: DIABETES | ||||||
| 03/09/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: Endocrinology | ||||||
| 04/19/2022 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Education | In-kind items and services | $12.33 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/30/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Diabetes Care | ||||||
| 10/21/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 10/09/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Consulting Fee | Cash or cash equivalent | $810.00 | General |
| Category: Diabetes | ||||||
| 10/08/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Consulting Fee | Cash or cash equivalent | $810.00 | General |
| Category: Diabetes | ||||||
| 09/16/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: Diabetes | ||||||
| 05/06/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.27 | General |
| 03/25/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 03/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 03/15/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.38 | General |
| 02/19/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 02/19/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.97 | General |
| 01/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 12/21/2020 | Abbott Laboratories | FreeStyle Lite system (Device) | Education | In-kind items and services | $99.98 | General |
| Category: Diabetes Care | ||||||
| 10/20/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: Diabetes | ||||||
| 10/02/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 10/02/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 09/25/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 09/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: DIABETES | ||||||
| 09/04/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: Diabetes | ||||||
| 09/01/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,048 | 2,273 | $358,668 | $128,705 |
| 2022 | 8 | 1,116 | 2,502 | $381,015 | $139,145 |
| 2021 | 8 | 1,204 | 2,644 | $371,353 | $151,028 |
| 2020 | 11 | 1,282 | 2,507 | $350,296 | $123,903 |
Total Patients
4,650
Total Services
9,926
Medicare Billing
$542,781
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 462 | 1,113 | $244,800 | $105,407 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $29,200 | $9,164 | 31.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 83 | 211 | $31,650 | $5,696 | 18.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 106 | 238 | $23,800 | $3,123 | 13.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 112 | 250 | $18,750 | $2,380 | 12.7% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 15 | 15 | $4,500 | $1,638 | 36.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 126 | 218 | $3,488 | $699.78 | 20.1% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 71 | 155 | $2,480 | $596.75 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 475 | 1,194 | $258,090 | $114,470 | 44.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $28,800 | $8,862 | 30.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 86 | 207 | $31,050 | $5,653 | 18.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 124 | 286 | $28,600 | $3,779 | 13.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 128 | 301 | $22,575 | $2,885 | 12.8% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 17 | 17 | $5,100 | $1,992 | 39.1% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 98 | 199 | $3,184 | $771.67 | 24.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 116 | 226 | $3,616 | $731.91 | 20.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 494 | 1,233 | $234,270 | $120,733 | 51.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 94 | 94 | $37,600 | $12,046 | 32.0% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 73 | 177 | $26,550 | $5,085 | 19.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 136 | 320 | $32,000 | $4,285 | 13.4% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2021 | 30 | 30 | $9,000 | $4,026 | 44.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 139 | 327 | $24,525 | $3,175 | 12.9% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 114 | 247 | $3,952 | $970.71 | 24.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 124 | 216 | $3,456 | $708.48 | 20.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 465 | 1,077 | $204,630 | $87,257 | 42.6% |
About Dr. Maan Barhoum, M.D
Dr. Maan Barhoum, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Libertyville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114993979.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maan Barhoum, M.D has received a total of $186,491 in payments from pharmaceutical and medical device companies, with $95.53 received in 2024. These payments were reported across 263 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($161,951).
As a Medicare-enrolled provider, Barhoum has provided services to 4,650 Medicare beneficiaries, totaling 9,926 services with total Medicare billing of $542,781. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Libertyville, IL
- Active Since 02/23/2006
- Last Updated 05/14/2008
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114993979
Products in Payments
- JARDIANCE (Drug) $75,019
- FARXIGA (Drug) $40,272
- INVOKANA (Drug) $21,162
- SOLIQUA (Drug) $17,691
- BYDUREON (Drug) $13,078
- TOUJEO (Drug) $11,948
- Synthroid (Drug) $5,337
- RYBELSUS (Drug) $1,620
- FreeStyle Lite system (Device) $99.98
- Dexcom G6 Transmitter (Medical Supply) $84.40
- TZIELD (Biological) $27.01
- SYNJARDY (Drug) $24.02
- Eversense (Device) $20.00
- FreeStyle Libre 2 (Device) $17.40
- RECORLEV (Drug) $12.33
- Belviq (Drug) $11.90
- DEXCOM G6 CGM SYSTEM (Device) $11.14
- Androgel (Drug) $7.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.